Cell and Gene Therapy Market Anticipates Significant Growth in 2024, According to BCC Research
The Bright Future of Cell and Gene Therapy Market in 2024
The cell and gene therapy market is on the brink of significant expansion, as detailed in BCC Research's recent report, "2024 Cell and Gene: Research Review." Released on June 20, 2025, the comprehensive report projects a robust trajectory for the industry, highlighting various innovations, investment trends, and the increasing global demand for advanced therapeutic solutions.
Market Projections
According to the findings published by BCC Research, we can expect the following growth rates across different areas within the cell and gene therapy sector:
- - Cell and Gene Therapy Tools and Reagents: The market is expected to escalate from $10.0 billion in 2024 to $16.7 billion by 2029, achieving a Compound Annual Growth Rate (CAGR) of 10.8%.
- - Cell Therapy Biomanufacturing: This particular segment is also on course to experience growth from $9.7 billion in 2024 to $16.7 billion by 2029 with a slightly higher CAGR of 11.5%.
- - Gene Synthesis Technologies: Projects reveal an increase from $2.0 billion in 2023 to $4.1 billion by 2028, which represents a remarkable CAGR of 15.8%.
Research Insights
The study delivers a lucid overview of the evolving landscape in the CGT industry. It elaborates on how technologies are utilized at every step of the development pipeline—from initial research phases to clinical applications and large-scale manufacturing. Key insights from the report include:
Wide-ranging Applications
CGT technologies are being leveraged in various stages of investigations such as preclinical studies, clinical trials, therapeutic production, viral vector development, and customized medicine.
Growth Stimulation Through Investment
A notable surge in funding and financial backing has been instrumental in accelerating innovation and expanding available options within the CGT field.
Innovation at the Heart
Recent advancements in gene editing, cellular modulation, and biomanufacturing are continually pushing the limits of what modern medicine can achieve.
Cost Barrier Challenges
Despite the positive outlook, one critical challenge remains: the high costs associated with therapy development which might impede broader acceptance across the market.
Conclusion
The findings of the 2024 Cell and Gene Research Review provide critical insights into the momentum of the sector, echoing the long-standing expertise BCC Research has maintained since its inception in 1971. Detailing trends, opportunities, and obstacles within the field, this report serves as an essential resource for stakeholders interested in the future of cell and gene therapy.
With the market witnessing rapid transformations, the ability to navigate uncertainties through informed decisions will prove to be invaluable. BCC Research strives to support innovation by offering custom research reports that present a thoroughly detailed analysis of the market landscape, ensuring that essential intelligence remains accessible. As an added offer, BCC Research is providing a 30% discount on all reports to encourage organizations to delve into the latest data and insights available.
For more information, or to acquire any reports, reach out via email at sales@bccresearch.com.
BCC Research stands ready to enhance your market intelligence and help you thrive amid changing times.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.